Humana Inc. (NYSE:HUM) – Stock analysts at Jefferies Group upped their Q2 2017 earnings estimates for Humana in a research report issued on Tuesday. Jefferies Group analyst D. Windley now forecasts that the firm will post earnings of $2.44 per share for the quarter, up from their prior forecast of $2.41. Jefferies Group has a “Buy” rating and a $206.00 price target on the stock. Jefferies Group also issued estimates for Humana’s Q3 2017 earnings at $3.66 EPS and Q4 2017 earnings at $2.93 EPS.

Other analysts also recently issued reports about the company. RBC Capital Markets reaffirmed a “buy” rating and set a $224.00 price target (up from $220.00) on shares of Humana in a research report on Friday, July 22nd. Credit Suisse Group AG reissued a “hold” rating and issued a $188.00 target price on shares of Humana in a research report on Tuesday, September 13th. Barclays PLC decreased their target price on Humana from $193.00 to $191.00 and set an “equal weight” rating for the company in a research report on Thursday, August 4th. Cantor Fitzgerald reissued a “buy” rating on shares of Humana in a research report on Monday, August 8th. Finally, Zacks Investment Research raised Humana from a “hold” rating to a “buy” rating and set a $197.00 target price for the company in a research report on Monday, July 25th. Five investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $205.00.

Earnings History and Estimates for Humana (NYSE:HUM)

Shares of Humana (NYSE:HUM) opened at 200.47 on Wednesday. The company has a market capitalization of $29.89 billion, a P/E ratio of 27.11 and a beta of 0.80. The company’s 50 day moving average price is $177.35 and its 200 day moving average price is $176.09. Humana has a 12 month low of $150.00 and a 12 month high of $203.48.

Humana (NYSE:HUM) last announced its quarterly earnings data on Friday, November 4th. The insurance provider reported $3.18 earnings per share for the quarter, topping the consensus estimate of $3.09 by $0.09. Humana had a return on equity of 12.32% and a net margin of 2.00%. The business earned $13.69 billion during the quarter, compared to the consensus estimate of $13.41 billion. During the same period in the prior year, the company earned $2.16 EPS. Humana’s revenue for the quarter was up 2.5% on a year-over-year basis.

Several hedge funds have recently made changes to their positions in the stock. Acrospire Investment Management LLC acquired a new position in Humana during the third quarter valued at $106,000. Point72 Asia Hong Kong Ltd acquired a new position in Humana during the second quarter valued at $126,000. Daiwa SB Investments Ltd. increased its position in Humana by 1.4% in the third quarter. Daiwa SB Investments Ltd. now owns 730 shares of the insurance provider’s stock valued at $129,000 after buying an additional 10 shares during the period. Brown Brothers Harriman & Co. acquired a new position in Humana during the third quarter valued at $134,000. Finally, People s United Financial Inc. increased its position in Humana by 141.6% in the third quarter. People s United Financial Inc. now owns 853 shares of the insurance provider’s stock valued at $151,000 after buying an additional 500 shares during the period. Hedge funds and other institutional investors own 93.94% of the company’s stock.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 27th. Investors of record on Thursday, January 12th will be paid a $0.29 dividend. This represents a $1.16 annualized dividend and a dividend yield of 0.58%. The ex-dividend date of this dividend is Tuesday, January 10th. Humana’s dividend payout ratio (DPR) is 15.96%.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

5 Day Chart for NYSE:HUM

Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.